tiprankstipranks
Trending News
More News >
Avadel Pharmaceuticals (AVDL)
NASDAQ:AVDL
Advertisement

Avadel Pharmaceuticals (AVDL) Revenue

Compare
802 Followers

Avadel Pharmaceuticals Revenue

Avadel Pharmaceuticals had a revenue of 77.47M in the quarter ending Sep 30, 2025, with 13.71%. This bring the company's revenue in the last twelve months to 248.52M, Decreased 12.41%. In the fiscal year ending Dec 31, 2024, Avadel Pharmaceuticals had annual revenue of 169.12M with 504.79% growth.
Revenue (ttm)
248.52M
Revenue Growth
79.88%
P/S Ratio
13.24
Revenue/Employee
$899,559
Employees
188
Market Cap
$2.24B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
169.12M141.15M+604.79%
Dec 31, 2023
27.96M-2,796,300,000.00%
Dec 31, 2022
Dec 31, 2021
-22.33M
Dec 31, 2020
22.33M-36.88M+37.72%
Dec 31, 2019
59.22M-44.05M+57.34%
Dec 31, 2018
103.27M-69.47M+59.78%
Dec 31, 2017
172.74M22.50M+114.97%
Dec 31, 2016
150.25M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis